Jiongyi Wang

533 total citations
13 papers, 441 citations indexed

About

Jiongyi Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiongyi Wang has authored 13 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Jiongyi Wang's work include FOXO transcription factor regulation (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Pain Management and Opioid Use (2 papers). Jiongyi Wang is often cited by papers focused on FOXO transcription factor regulation (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Pain Management and Opioid Use (2 papers). Jiongyi Wang collaborates with scholars based in China. Jiongyi Wang's co-authors include Bin Jiang, Haihua Yuan, Mei Zhao, Wenying Zhang, Feng‐Hou Gao, Feng Liu, Yanjie Zhang, Xiaodi Gong, Wenying Zhang and Feng Liu and has published in prestigious journals such as Drug Discovery Today, Frontiers in Oncology and Lung Cancer.

In The Last Decade

Jiongyi Wang

12 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiongyi Wang China	9	224	188	133	79	51	13	441
Lu-Ming Liu China	14	315 1.4×	178 0.9×	184 1.4×	48 0.6×	43 0.8×	21	548
Keara L. Redmond United Kingdom	9	310 1.4×	205 1.1×	60 0.5×	49 0.6×	63 1.2×	11	510
Tatsuhiro Ohgami Japan	15	241 1.1×	151 0.8×	97 0.7×	45 0.6×	28 0.5×	40	602
Jorge Brañes Chile	10	178 0.8×	134 0.7×	230 1.7×	51 0.6×	17 0.3×	18	513
Seong Whan Jeong South Korea	9	344 1.5×	128 0.7×	71 0.5×	37 0.5×	40 0.8×	12	439
Masataka Amisaki Japan	14	157 0.7×	243 1.3×	127 1.0×	148 1.9×	19 0.4×	34	567
Ramin Altaha United States	9	153 0.7×	181 1.0×	70 0.5×	143 1.8×	38 0.7×	23	411
Futao Hou China	8	297 1.3×	140 0.7×	164 1.2×	42 0.5×	38 0.7×	11	463
Greice Andreotti de Molfetta Brazil	13	414 1.8×	42 0.2×	339 2.5×	31 0.4×	36 0.7×	34	649
Domenico Mastrangelo Italy	12	489 2.2×	144 0.8×	100 0.8×	90 1.1×	63 1.2×	36	756

Countries citing papers authored by Jiongyi Wang

Since Specialization

Citations

This map shows the geographic impact of Jiongyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiongyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiongyi Wang more than expected).

Fields of papers citing papers by Jiongyi Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiongyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiongyi Wang. The network helps show where Jiongyi Wang may publish in the future.

Co-authorship network of co-authors of Jiongyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiongyi Wang. A scholar is included among the top collaborators of Jiongyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiongyi Wang. Jiongyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Zhang, Lili, et al.. (2024). ZNF143-mediated upregulation of MEX3C promotes hepatocellular carcinoma progression. Clinics and Research in Hepatology and Gastroenterology. 48(10). 102492–102492.

Qian, Chengcheng, Wenying Zhang, Jiongyi Wang, et al.. (2021). Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients. Frontiers in Oncology. 11. 710704–710704. 22 indexed citations

Yuan, Haihua, Jiongyi Wang, Xiaohua Hu, et al.. (2020). Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection. Future Oncology. 16(10). 559–571. 17 indexed citations

Wang, Lili, Wenying Zhang, Jiongyi Wang, et al.. (2019). Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients. International Journal of Colorectal Disease. 34(4). 589–597. 33 indexed citations

Qin, Xiaoyu, Jiongyi Wang, Xinxin Wang, et al.. (2017). Targeting Rabs as a novel therapeutic strategy for cancer therapy. Drug Discovery Today. 22(8). 1139–1147. 47 indexed citations

Tian, Cong, Jiongyi Wang, Meiling Wang, et al.. (2016). Morphine versus methylprednisolone or aminophylline for relieving dyspnea in patients with advanced cancer in China: a retrospective study. SpringerPlus. 5(1). 1945–1945. 2 indexed citations

Kong, Feifei, Zengqiang Qu, Haihua Yuan, et al.. (2014). Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Oncology Reports. 31(6). 2660–2668. 75 indexed citations

Zhang, Chao, Jing Shi, Mang‐Hua Xu, et al.. (2014). Abnormal activation of the EGFR signaling pathway mediates the downregulation of miR-145 through the ERK1/2 in non-small cell lung cancer. Oncology Reports. 31(4). 1940–1946. 25 indexed citations

Kong, Feifei, Haihua Yuan, Jiongyi Wang, et al.. (2014). FOXM1 Regulated by ERK Pathway MediatesTGF-1-Induced EMT in NSCLC. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 22(1). 29–37. 27 indexed citations

10.

Gong, Xiaodi, et al.. (2013). Gene Polymorphisms of OPRM1 A118G and ABCB1 C3435T May Influence Opioid Requirements in Chinese Patients with Cancer Pain. Asian Pacific Journal of Cancer Prevention. 14(5). 2937–2943. 49 indexed citations

11.

Gong, Xiaodi, et al.. (2013). [Effects of AG1478 on the expression of FOXM1 gene via FOXO3a in non-small cell lung cancer cells].. PubMed. 35(8). 572–8. 1 indexed citations

12.

Zhao, Mei, Feng‐Hou Gao, Jiongyi Wang, et al.. (2011). JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer. Lung Cancer. 73(3). 366–374. 138 indexed citations

13.

Zhao, Mei, Feng Liu, Jiongyi Wang, et al.. (2011). [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].. PubMed. 91(6). 375–81. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact